Fertility tech refers to technology driven solutions used by men and women to monitor or preserve fertility. Fertility monitoring helps couples increase their chance of conceiving. Fertility preservation reduces the impact of one’s biological clock when making decisions on conceiving and family planning. The fertility tech ecosystem also includes players who support the fertility tech industry by offering patients assistance in navigating their fertility care decision-making and financing. These tech tools are gaining traction supported by several demographic, social, and economic factors such as delaying parenthood, decreasing male fertility, and a shortage of fertility clinics.
The fertility tech market primarily includes products engaged in fertility monitoring and tracking, which includes at-home fertility/hormone measuring kits, fertility and ovulation monitoring and tracking app, and the men’s fertility test and sperm storage segments as well as fertility preservation services. Notably, among the disruptors and watchlist companies, egg freezing services had the smallest number of companies.
Most firms in the industry are pure-play companies, with the exception of leading disruptors Kindbody and Prelude Fertility. Around half of the disruptors and watchlist companies identified in this report are in the go-to-market stage, with the remainder split between minimum viable product and expansion stages.
Integrated players LetsGetChecked and Prelude Fertility remain highest funded, followed by financial assistance players
While most disruptors cater to a single segment in the fertility tech ecosystem, one of the highest funded disruptors, Prelude Fertility, distinguishes itself by offering a range of services. Prelude’s offering includes sperm and egg freezing, embryo creation and transfer, and genetic screening for inherited diseases and abnormalities. The highest funded disruptor in this space as of April 2022 was fertility test kit provider, LetsGetChecked.
Most disruptors compete with their segmental peers with similar products, with the exception of at-home fertility/hormone measuring kits for women, where different bodily components are used to measure hormones. For instance, Natural Cycles uses temperature to measure ovulation, whereas Kegg measures cervical fluids to track hormone levels. Furthermore, Apricity (Woom) is an exception to most period and fertility monitoring apps, as it looks to track and give more information on bodily functions, while other apps typically look to predict future cycles using the data.
Incumbents in the fertility tech market include fertility clinics, medical device manufacturers, and testing kit providers. These companies generally opt to produce their own in-house innovations for the fertility tech market, as an extension of their current products and services. For instance, EarlySense offers a range of healthcare monitoring devices and also produces a device to monitor hormones and fertility for women.
DNA Diagnostics Center, a DNA diagnostics and testing provider, acquired Sperm Check in May 2018 to expand their testing to the fertility industry.
In addition to the healthcare enterprises, Google also has interests within the fertility tech industry, through subsidiary Fitbit’s wearables, which offers fertility tracking products, and has invested in a disruptor KindBody, an egg freezing service provider.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.